To assess detailed familial risks for medically diagnosed urolithiasis (UL, urinary tract stone disease) based on nationwide hospital and population records.
Introduction
Urolithiasis (UL) or urinary tract stone disease typically originates with stones formed in the kidney that leave the body in the urine stream [1, 2] . Small stones may pass without causing symptoms but stones of >5 mm can cause blockage of the ureter, which can result in severe pain. Stones in the bladder are another cause of outflow obstruction, caused by blockage of the urethra and leading to inability to empty the bladder completely. UL is a common disease with 1-15% of people affected globally at some point in their life, with the condition and the disease prevalence increasing [1, 2] . UL can be a recurrent disease and about half of people that have had kidney stones will experience recurrence of the condition within 5-10 years [2] . Stone formation is due to a combination of genetic and environmental factors. Risk factors include high urine calcium levels, obesity, certain foods, some medications, calcium supplements, hyperparathyroidism, gout, diabetes, hypertension, and not drinking enough fluids [2] . Stones may be classified by their location (kidney, ureter, and bladder) or by their composition such as calcium-based stones, which are the most common ones [3] .
Hypercalciuria is considered the most common metabolic abnormality associated with UL, and was found in some 60% of patients with the condition; family history can often be traced [4] . The aetiological role of family history was previously recognised in the 1890s [4] . However, much of the family history literature is quite old and some of the risk estimates are unrealistically high (e.g. >50% of family members affected) most probably due to differences in study designs and inaccurate ascertainment of renal stones in relatives, as discussed by Stechman et al. [4, 5] . A large followup study, which was published in 1997 on kidney stones in male health professionals, reported a familial relative risk of 2.57 and higher in early onset cases [6] . An Icelandic study of kidney stones found about equal risks amongst first-degree relatives and could show significant associations up to fifth-degree relatives [5] . Another study found no relationship between UL family history and abnormal calcium or oxalate excretion rates [7] . A twin study estimated heritability of UL at as high as 56% [8] . UL may be caused by rare monogenic inherited metabolic disorders, such as adenine phosphoribosyltransferase deficiency, cystinuria, Dent disease, familial hypomagnesemia, and primary hyperoxaluria [9] . These disorders are often diagnosed in the pediatric population. Recently, many predisposing genes have been described for UL, e.g. variants associated with kidney stones and involved in phosphate homeostasis ( [3, 10, 11] .
In the present study, we used nationwide Swedish hospital records of inpatients and outpatients with UL diagnoses and linked the individual data to family records through the nationwide Multigeneration Register. We describe familial risks for UL subtypes (kidney, ureter, mixed, and bladder) depending on sex, familial relationships (parent-offspring, sibling), number of affected family members, and number of recurrent UL episodes. Environmental associations are assessed by spouse concordance for UL. The present study is by far the largest family study on UL and the only one with the Icelandic study relying on nationwide records of medically diagnosed UL and registered family structure [5] .
Patients/Subjects and Methods
Family relationships were obtained from the Multigeneration Register, which contains the Swedish population in families and spans more than a century. 'The offspring generation' was born after 1931 and by the year 2012 the offspring generation had reached age 80 years. Siblings can be defined only in the offspring generation. The offspring generation with information concerning both parents totaled 8.5 million index individuals. Patients with UL were identified using the nationwide Swedish Hospital Discharge Register and the Outpatient Register (2001-2012). The first UL diagnosis in either register was factored in and a patient was only entered once unless effects of recurrence were analysed. Information from the registers was linked at the individual level via the national 10-digit civic registration number issued at birth or upon immigration to everyone in Sweden. In the linked dataset, civic registration numbers were replaced with serial numbers to ensure anonymity. Revisions 9 (1987 Revisions 9 ( -1996 and 10 (1997-2012) of the International Classification of Diseases (ICD) were used to identify UL diagnostic codes. The 'mixed' UL diagnosis was unspecified or did not distinguish kidney or ureter locations. It included the ICD-9 code 592.9, urinary calculus, unspecified, and the ICD-10 codes N20.2, calculus of kidney with calculus of ureter and N20.9 urinary calculus, unspecified. Only 54 500 patients were diagnosed during the ICD-9 period, compared to 166 600 in the ICD-10 period. In the latter period, 36% of the patients were inpatients and 64% were outpatients. Amongst ureter and bladder patients, a small majority were inpatients, while for other diagnoses outpatients were a large majority.
Standardised incidence ratios (SIRs) were calculated as the ratio of observed to expected number of cases. The expected numbers were calculated for all individuals without a history of UL (essentially the whole Swedish population), and the rates were standardised by 5-year-age, gender, period (5-yeargroup), socioeconomic status, and residential area. The 95% CI of the SIR was calculated assuming a Poisson distribution. SIRs were calculated for offspring whose parent, siblings or parents and siblings were diagnosed with UL.
To assess possible roles of environmental risk factors for familial clustering of UL, we determined SIRs for UL in wives when husbands were diagnosed with UL, and similarly for husbands by wives' UL. The period at risk for spouses was defined to start at the birth year of their first common child or at the first year that they were registered as living at the same address, whichever came first. The follow-up was terminated at UL diagnosis, death or when spouses no longer lived at the same address [12] .
Ethics approval: The study was approved by the Regional Ethical Review Board of Lund University (no. 2012/795).
Results
Patient numbers and mean diagnostic ages for the covered ULs are shown in Table 1 . The total population included 13.3 million individuals with an almost equal number of men and women. The total UL population amounted to 211 718 patients including 91 397 ureter UL patients representing the largest group and 18 459 bladder UL patients representing the smallest group. Men outnumbered women (66.6% of all patients were male). The mean and median diagnostic ages (i.e. first hospital contact) were 53 years. The overall incidence was 77.6 per 100 000 person-years.
Familial risks are shown in Table 2 for concordant and discordant family history. For all UL, male risk was 2.00 and for females it was 2.10. The difference was small but because of large numbers the 95% CIs did not overlap. Male SIRs for all kidney (2.04) and all ureter UL (2.07) patients were identical but they were lower for mixed (1.95) and particularly for bladder UL patients (1.52). For women, the SIR of 2.21 for all kidney UL patients was the highest and SIR of 1.48 for bladder UL patients was the lowest. Concordant subtypes invariably showed the highest SIRs, 2.18 for kidney (both sexes), 2.20 for ureter, 2.04 for mixed, and 1.93 for bladder UL. Notably, the 480 © 2017 The Authors BJU International © 2017 BJU International SIR for male bladder UL risk was 2.24, the highest male risk, but for women this SIR of 0.62 was not significant with only five cases. The highest female SIR of 2.20 was for ureter UL. The total number of familial UL patients was 19 809 in the offspring generation. As the total of UL patients in this generation was 130 091, thus familial cases accounted for 15.2% of all patients with UL.
Age-specific incidence for all UL patients with and without family history is shown in Fig. 1 . Male incidence increased continually up to age ≥75 years and was steeper for those with a family history. For women, an early onset incidence was higher than for men; the early onset shoulder was reached at <35 years, both for familial and non-familial cases, and the subsequent increase was modest. At age ≥75 years without family history, the female incidence was only~35% of the male rate. A large difference in the incidence rate for familial and non-familial UL occurred between the ages of 15-25 years. Table 3 shows familial risks for each type of UL in four age groups when probands were diagnosed with any UL. For men, SIRs for kidney and ureter stones decreased by age group; for bladder stones the SIRs were essentially unchanged. For women, the youngest two age groups showed the highest risks. The highest number of familial cases for bladder UL was in the age group ≥60 years compared to the age group 40-59 years for the other UL types.
In Table 4 , we show familial risk for all UL by the number and type of proband. SIR was lower for men when the father was the proband (1.88) compared to women when the mother was the proband (2.26). The modest excess by the female proband was seen in most comparisons. Considering only parental probands and both sexes, the SIR increased from 1.84 when one parent was affected to 3.54 when both parents were affected. Considering sibling probands and both sexes, the SIR was 1.79 when one sibling was affected but it increased to 24.91 when two siblings were affected, and it did not especially increase (28.03) when three or more siblings were affected. When a parent and a sibling were affected, the risk to offspring increased to 3.29 and it increased to 50.28 when a parent and two siblings were affected. In rare families, with an even higher number of affected probands, the SIR did not increase further. SIRs for spouses were identical, 1.29 for men by an affected wife and 1.28 for women by an affected husband. Table 5 shows familial risks for all UL for patients who had one or more episodes occurring at least 1 year apart. For men, the SIRs increased from 1.86 (only one episode) to 2.61 (≥4 episodes). For women, the SIRs increased from 1.97 to 2.63.
Discussion
The present study used nationwide hospital records on 211 718 inpatients and outpatients with medically diagnosed UL. Thus the data constitute, as far as we know, by far the largest family study on UL yet published. The main novel findings were the strong dependence of familial risk on the number of affected family members, higher risk for concordant than discordant type of UL, and moderate increase in familial risk in recurrent cases. Other findings included effect of diagnostic age, somewhat higher risk for women than for men, and only very modest risks between spouses, which suggest a minor contribution of shared environmental factors on the familial risk. Thus, the overall data points to the underlying genetic causes for the observed familial clustering and establishes the genetic landscape of UL. Familial cases accounted for 15.2% of all UL cases, which compared to 12.8% for kidney stones as reported in 1997 [6] . The overall incidence of UL was 77.6 per 100 000 personyears, which is in the range reported for the USA [13] .
A limitation of the present study is that outpatient data, with more cases than amongst inpatients, were available only since 2001; thus the follow-up from this source spanned 12 years. The relatively short follow-up time implied that siblings were the more likely familial pairs rather than parents and offspring. Another potential limitation was that if patients were treated only in primary care they would have been missed. However, the proportion of such patients is probably small because in Sweden patients with acute renal colic or blood in urine would traditionally visit a hospital emergency department, and diagnostics and treatment would take place in urology departments [14] .
The number of affected probands appeared to influence familial risk close to a multiplicative fashion. When one parent was affected the risk to offspring was 1.84 but when both parents were affected the risk was 3.54, slightly higher than the multiplicative estimate of 3.38 (1.84 9 1.84); the additive estimate is much lower, 2.68 (1.84 + 1.84 À 1.00 = 2.68). Similarly, when only one parent (SIR 1.84) and only one sibling (1.79) were affected the multiplicative estimate was 3.29, exactly the observed risk of 3.29. Moreover, the identical risk for parent-offspring and sibling pairs leaves little space for influence by recessive or childhood shared environmental effects. When a parent (1.84) and two siblings (24.91) were affected the multiplicative estimate of 45.83 was within the 95% CIs of the observed risk of 50.28. The general interpretation of the multiplicative effect is that the underlying genes interact with each other, and function on the same pathway [15] . When two or more siblings (no affected parents) were affected the risks were very high (24.91 and 28.03). This could imply involvement of high-penetrant genes in these 1 061 (856 + 74 + 116 + 15) affected individuals, which would account for 5.3% of all familial cases (1 061/19 809; 5.3%). Such apparent high-risk families could be a manifestation of the rare high-penetrant genes described for UL [3, 9, 10] . Overall the patterns of familial risks in UL (multiplicative effects and high sibling risks) were similar to those described for type 2 diabetes by us [16] .
The lower incidence of UL and somewhat higher familial risk in women has some resemblance to 'the Carter effect', which was first described for pyloric stenosis [17] . This phenomenon of a strong familial effect in the gender of low background incidence has been observed also for kidney stones in Iceland and for some cancers [5, 18] . The likely mechanism is that in the low background environment genetic effects are relatively stronger compared to a high background environment. However, as shown in Fig. 1 , young women (aged 20-35 years) had a higher incidence compared to men, which is consistent with the high UL risk around pregnancy [19] .
Although hypercalciuria and other metabolic abnormalities are considered important in the aetiology of UL, the modest risk of 1.29 between spouses suggests that shared dietary habits do not appreciably influence the risk of UL [4] . This may be in line with findings of a follow-up study on kidney stones, which found that the familial risk was not modified by dietary intake of calcium [6] . The shared familial risk between patients with kidney and ureter UL is understandable in view of the shared aetiology. Despite the assumption that kidney and bladder UL have different aetiologies,~50% of the concordant familial risk remained for discordant UL, suggesting considerable pathophysiological sharing between kidney and bladder UL. This would be consistent with the data on men with bladder outlet obstruction due to benign prostatic hyperplasia; patients with bladder stones were more likely to have a renal UL history compared to men without bladder stones [20] . A possible explanation for this might be that macroscopically invisible and clinically asymptomatic stones were generated in the kidney and passed to the bladder, where the 'seed stones' grew gradually larger, facilitated by retention of urine. The considerably older age of bladder than kidney UL patients would be in line with such a mechanism (Table 3 ).
In conclusion, the present results provide strong evidence for the genetic basis of UL. Familial cases accounted for 15.2% all cases, with highest risks for concordant types of UL. The patterns of familial clustering suggested multiplicative interactions with a high-risk component of 5.3%, probably involving high-penetrant genes. Clinical guidelines for prevention of UL specify the importance of taking a family history but detailed advice focuses on the prevention of recurrence rather than of familial risk [2, 21, 22 ]. Yet such guidance should be equally applicable when family history is the only indication, including analysis of stones, medical history, dietary and lifestyle patterns, and follow-up enabling treatment before complicated stone formation arise.
